Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

650 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic Role of a New Index (RAPID Index) in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib: Training and Validation Cohort.
Casadei-Gardini A, Solaini L, Riggi L, Molinaro E, Dadduzio V, Rizzato MD, Pellino A, Faloppi L, Marisi G, Ulivi P, Canale M, Orsi G, Rovesti G, Andrikou K, Spallanzani A, Gelsomino F, Foschi FG, Conti F, Cucchetti A, Ercolani G, Biason P, Lonardi S, Cascinu S, Scartozzi M. Casadei-Gardini A, et al. Among authors: cascinu s. Gastrointest Tumors. 2019 Oct;6(3-4):71-80. doi: 10.1159/000501593. Epub 2019 Aug 20. Gastrointest Tumors. 2019. PMID: 31768351 Free PMC article.
Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis.
Scartozzi M, Baroni GS, Faloppi L, Paolo MD, Pierantoni C, Candelari R, Berardi R, Antognoli S, Mincarelli C, Risaliti A, Marmorale C, Antico E, Benedetti A, Cascinu S. Scartozzi M, et al. Among authors: cascinu s. J Exp Clin Cancer Res. 2010 Dec 15;29(1):164. doi: 10.1186/1756-9966-29-164. J Exp Clin Cancer Res. 2010. PMID: 21159184 Free PMC article.
Angiogenetic pathway as a therapeutic target in renal cell carcinoma.
Bianconi M, Scartozzi M, Faloppi L, Bittoni A, Maccaroni E, Giampieri R, Del Prete M, Burattini L, Cascinu S. Bianconi M, et al. Among authors: cascinu s. Anal Quant Cytol Histol. 2012 Feb;34(1):15-22. Anal Quant Cytol Histol. 2012. PMID: 22590815 Review.
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib.
Scartozzi M, Bianconi M, Faloppi L, Loretelli C, Bittoni A, Del Prete M, Giampieri R, Maccaroni E, Nicoletti S, Burattini L, Minardi D, Muzzonigro G, Montironi R, Cascinu S. Scartozzi M, et al. Among authors: cascinu s. Br J Cancer. 2013 Mar 19;108(5):1126-32. doi: 10.1038/bjc.2012.501. Epub 2012 Nov 29. Br J Cancer. 2013. PMID: 23511629 Free PMC article.
650 results